Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dr. z who wrote (631)	4/25/1997 12:42:00 PM
From: margie	of 6136

David S has been promoting shorting agph on other threads. \| Next \| Respond \| To: Justin Volentine (12 ) From: David S. Apr 22 1997 1:57AM EST Reply #13 of 23 I don't follow Clear Channel, but regarding an AIDS cure, AGPH has as good a chance of finding a cure for AIDS as I do beating Tiger Woods in a round of golf. It's going to be interesting to see what happens to AGPH when they file their secondary stock offering. As prices are determined by supply and demand, a few extra million shares of supply, with some of it being insider stock should put reality back into its valuation. Keep in mind that right now, AGPH is a single product company. Remember David. Amgen is a two drug company.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next